Bone Scan Index as a prognostic imaging biomarker during androgen deprivation therapy.

Summary, in English

Bone Scan Index (BSI) is a quantitative measurement of tumour burden in the skeleton calculated from bone scan images. When analysed at the time of diagnosis, it has been shown to provide prognostic information on survival in men with metastatic prostate cancer (PCa). In this study, we evaluated the prognostic value of BSI during androgen deprivation therapy (ADT).

• Författare: Mariana Reza; Anders Bjartell; Mattias Ohlsson; Reza Kaboteh; Per Wollmer; Lars Edenbrandt; Elin Trägårdh
• Avdelning/ar: Nuklearmedicin, Malmö; BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation; Urologisk cancerforskning, Malmö; Department of Astronomy and Theoretical Physics - Has been reorganised; Klinisk fysiologi och nuklearmedicin, Malmö; EpiHealth: Epidemiology for Health
• Publiceringsår: 2014
• Språk: Engelska
• Publikation/Tidskrift/Serie: EJNMMI Research
• Volym: 4
• Fulltext: - 842 kB; Download statistics
• Länkar: http://www.ncbi.nlm.nih.gov/pubmed/25386390?dopt=Abstract; http://dx.doi.org/10.1186/s13550-014-0058-y
• Dokumenttyp: Artikel i tidskrift
• Förlag: Springer
• Ämne: Radiology and Medical Imaging
• Aktiv: Published
• Forskningsgrupp: Nuclear medicine, Malmö; Urological cancer, Malmö; Clinical Physiology and Nuclear Medicine, Malmö
• ISBN/ISSN/Övrigt: ISSN: 2191-219X